MidMarketNow
Get the Weekly

XGEN Venture

—

SectorsHealthcare1
Regions—
Last activity

Activity, last 12 months

XGEN Venture — deals per month, last 12 months
XGEN Venture — deals per month, last 12 months
MonthDeals
July 20250
August 20250
September 20250
October 20250
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260

Deal history

  1. EpilepsyGTx lands EUR 31.75m to advance epilepsy gene therapy

    UK gene therapy start-up EpilepsyGTx has raised EUR 31.75 million in Series A funding from XGEN Venture, the British Business Bank and a global biopharma to take EPY201 into Phase 1/2a trials for focal refractory epilepsy.

We use privacy-respecting product analytics to understand how readers use MidMarketNow and improve it. No personal data (email, IP) is sent. See our privacy policy.